Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial
===========================================================================================================================================================================

* Yongxiang Xia
* Weiwei Tang
* Xiaofeng Qian
* Xiangcheng Li
* Feng Cheng
* Ke Wang
* Feng Zhang
* Chuanyong Zhang
* Donghua Li
* Jinhua Song
* Hui Zhang
* Jie Zhao
* Aihua Yao
* Xiaofeng Wu
* Chen Wu
* Guwei Ji
* Xisheng Liu
* Feipeng Zhu
* Lang Qin
* Xuan Xiao
* Zhenhua Deng
* Xiangyi Kong
* Si Li
* Yangyang Yu
* Wenjing Xi
* Wanglong Deng
* Chuang Qi
* Hanyuan Liu
* Liyong Pu
* Ping Wang
* Xuehao Wang